Neuropharmagen trademark for pharmacogenetics SAAS platform

USPTO received trademark application TM98671767 for NEUROPHARMAGEN filed by an unspecified applicant on July 29, 2024. The application covers International Class 044 medical services including pharmacogenetic analysis software (SAAS/PAAS), genetic testing and research services, medical diagnostic services, and clinical trial support. The application is filed on an Intent-to-Use basis with a deadline of March 31, 2026.

Health Elevation 360 Trademark Application - Class 44 Health Services

USPTO received trademark application TM98635213 for 'HEALTH ELEVATION 360' covering health, nutrition, and wellness counseling services (Class 44) along with athletic apparel and hair care products. The application was filed on July 5, 2024, under Intent to Use provisions with an extension deadline of March 31, 2026.

PSYCHIATRY DECONSTRUCTED Trademark Renewal

The USPTO renewed trademark registration TM98471657 for PSYCHIATRY DECONSTRUCTED on March 31, 2026. The mark covers medical services including psychiatric consultation, psychological consultation, and healthcare education information. The original application was filed March 27, 2024.

Playhouse Speech Therapy Trademark Renewal

USPTO renewed trademark TM98428511 for Playhouse Speech Therapy on March 31, 2026, extending trademark protection for speech therapy services. This is a routine administrative renewal with no new obligations or policy changes imposed on trademark holders.

Coalition Urges Congress to Pass Combating Xylazine Act

West Virginia Attorney General JB McCuskey joined a bipartisan coalition of 41 attorneys general in urging Congress to pass the Combating Xylazine Act. The proposed legislation would classify xylazine under Schedule III of the federal Controlled Substances Act and authorize the DEA to track manufacturing of the drug. Xylazine, a veterinary tranquilizer frequently combined with fentanyl, has contributed to increasing overdose deaths and complicates rescue efforts due to reduced naloxone efficacy.

Attorney General Pushes for Authority to Combat Illegal Prison Drone Drops

West Virginia Attorney General JB McCuskey joined 20 other attorneys general in sending a letter to the Trump administration requesting expanded authority for state and local law enforcement to detect, track, and disable unauthorized drones used to drop contraband into prisons. The letter addresses a gap in current federal law that limits counter-drone authority to federal agencies, leaving correctional officials without tools to intervene in real time.

AG Wilson Statement on Captain Sams Spit Litigation Settlement

South Carolina Attorney General Alan Wilson announced the State Fiscal Accountability Authority's approval of a settlement in the Captain Sams Spit lawsuit, saving taxpayers up to $200 million. The dispute originated in 2009, and Governor McMaster supported the settlement which passed the House overwhelmingly and is pending in the Senate.

SCOTUS strikes Colorado conversion therapy ban, free speech win

SCOTUS strikes Colorado conversion therapy ban, free speech win

Renewal of Designation of Agents Information Collection Request

FMCSA announced its plan to renew OMB Control No. 2126-0015 for the "Designation of Agents, Motor Carriers, Brokers and Freight Forwarders" information collection. The renewal covers Form BOC-3 filings by motor carriers, freight forwarders, and property brokers to designate process agents as required under 49 U.S.C. 13902-13904. The estimated annual burden is 18,503 hours across 110,799 respondents.

CDL Drug and Alcohol Clearinghouse Information Collection Renewal

FMCSA announced the renewal of its approved Information Collection Request for the Commercial Driver's License Drug and Alcohol Clearinghouse, inviting public comments through June 1, 2026. The Clearinghouse, established by the 2016 final rule with a January 2020 compliance date, tracks CDL holders who test positive for controlled substances or misuse alcohol and tracks completion of the return-to-duty process.